Skip to Main Content

Paper Details

Tumor-Naïve Circulating Tumor DNA as an Early Response Biomarker for Patients Treated With Immunotherapy in Early Phase Clinical Trials.
JCO Precis Oncol
3
2023
Author NameAffiliation
Xue Wu
Lillian L SiuPrincess Margaret Cancer Centre, University Health Network, University of Toronto
Philippe L BedardPrincess Margaret Cancer Centre, University Health Network, University of Toronto
  • 1 - 3

Datasets

Release 1.2